Canton Strategic Holdings (CNTN) Income towards Parent Company (2021 - 2026)

Canton Strategic Holdings (CNTN) posted Income towards Parent Company of -$47.3 million for Q1 2026, down 248.26% on a QoQ basis from -$13.6 million in Q4 2025, and down 1762.66% year-over-year from $2.8 million in Q1 2025.

Canton Strategic Holdings (CNTN) Income towards Parent Company (2021 - 2026) Analysis & Trends

Canton Strategic Holdings' Income towards Parent Company history runs 6 years deep, the most recent figure standing at -$47.3 million for Q1 2026.

  • Quarterly Income towards Parent Company fell 1762.66% year-over-year to -$47.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$64.9 million (down 421.27% YoY) and the FY2025 annual result came in at -$42.9 million, down 252.06% from the prior year.
  • Income towards Parent Company was -$47.3 million for Q1 2026 at Canton Strategic Holdings, down from -$13.6 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$188679.0 in Q4 2022 and bottomed at -$47.3 million in Q1 2026.
  • A 5-year average of -$5.6 million and a median of -$2.3 million in 2023 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company surged 47.53% — and 2026, when it sank 1762.66%.
  • Canton Strategic Holdings' Income towards Parent Company stood at -$188679.0 in 2022, then sank by 1211.1% to -$2.5 million in 2023, then plunged by 53.08% to -$3.8 million in 2024, then tumbled by 259.0% to -$13.6 million in 2025, then slumped by 248.26% to -$47.3 million in 2026.
  • Business Quant data shows CNTN's Income towards Parent Company at -$47.3 million in Q1 2026, -$13.6 million in Q4 2025, and -$2.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn -
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn -
3 Akari Therapeutics 976.78 Bn 976.78 Bn -
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 63.06 Bn 63.06 Bn -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn
10 Canton Strategic Holdings 430.99 Mn 430.99 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -47.34 Mn
Dec 31, 2025 -13.59 Mn
Sep 30, 2025 -2.10 Mn
Jun 30, 2025 -1.86 Mn
Mar 31, 2025 -2.54 Mn
Dec 31, 2024 -3.79 Mn
Sep 30, 2024 -3.80 Mn
Jun 30, 2024 -2.33 Mn
Mar 31, 2024 -2.26 Mn
Dec 31, 2023 -2.47 Mn
Sep 30, 2023 -1.82 Mn
Jun 30, 2023 -2.34 Mn
Mar 31, 2023 -2.69 Mn
Dec 31, 2022 -188,679.00
Sep 30, 2022 -2.13 Mn
Jun 30, 2022 -1.64 Mn
Mar 31, 2022 -2.95 Mn
Dec 31, 2021 -359,593.00
Sep 30, 2021 -777,113.00
Jun 30, 2021 -1.29 Mn